# MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

> **NCT05132439** · PHASE3 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 200 (estimated)

## Conditions studied

- Intermittent Claudication

## Interventions

- **DRUG:** Metformin ER
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05132439
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2027-02-28
- **Final completion:** 2032-02-28
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05132439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05132439, "MetfOrmin BenefIts Lower Extremities With Intermittent Claudication". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05132439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*